STRIDE INC (LRN) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:LRN - US86333M1080 - Common Stock
65.95 USD
+0.5 (+0.76%)
65.95 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to LRN. The Buy consensus is the weighted average rating of the current analysts ratings.
LRN was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LRN.
In the previous month the buy percentage consensus was at a similar level.
LRN was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-29 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-10-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-24 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-30 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-28 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-30 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-01-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-29 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-10-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-20 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-08 | BMO Capital | Maintains | Outperform -> Outperform |
STRIDE INC / LRN FAQ
What is the consensus rating for STRIDE INC (LRN) stock?
The consensus rating for STRIDE INC (LRN) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed STRIDE INC (LRN)?
The number of analysts covering STRIDE INC (LRN) is 11.